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Introduction: Smoking can cause a variety of pulmonary interstitial diseases.
Pulmonary fibrosis has traditionally been considered a non-smoking-related disease.
Recently, however, evidence of smoking-induced fibrosis has emerged.
Subjects and methods: A group of eight patients from the pulmonary clinic in Rabin
Medical Center with a combine presentation of fibrosis and emphysema was
identified retrospectively. All patients underwent chest computed tomography and
pulmonary function tests. One patient underwent lung–heart transplantation and a
complete review of his lung pathology was obtained. Transbronchial biopsy was
performed in 3 additional patients and echocardiography was performed to evaluate
the pulmonary vasculature.
Results: Upper-lobe emphysema with bulluos changes was found in all patients. In
addition, a basal interstitial process was recognized, ranging from ground glass
opacities to severe pulmonary fibrosis, with honeycombing. The radiological findings
matched the pathological results of combined emphysema and usual interstitial
pneumonia. Pulmonary function tests were also in accord, showing severe
hypoxemia with mild obstruction, normal-to-mildly reduced lung volumes and a
severe decrease in diffusion capacity. Most of the patients had moderate-to-severe
pulmonary hypertension as well as diffuse coronary artery disease.Elsevier Ltd. All rights reserved.
9377221/3; fax: +972 3 9242091.
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Pulmonary interstitial diseases 949Conclusion: Our findings are in line with emerging evidence that the spectrum of
interstitial damage caused by smoke includes not only Langerhans cell hystiocytosis,
respiratory bronchiolitis or desquamative interstitial pneumonia but also advanced
usual interstitial pneumonitis as well. We believe that in some patients smoking
plays a destructive role by a variety of mechanisms and can cause emphysema, lung
fibrosis as well as pulmonary vasculopathy and hypertension. Future studies are
needed to define the genetics and pathophysiology of this uncommonly reported
clinical syndrome.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Emphysema is a well-known consequence of heavy
smoking. It more commonly affects the upper lobes
with bullous formation. Smoking may also cause
a spectrum of interstitial lung diseases, namely
Langerhans cell hystiocytosis, and respiratory
bronchiolitis-associated interstitial pneumonia and
desquamative interstitial pneumonia. Pulmonary
fibrosis, in the forms of usual interstitial pneumonia
or non-specific interstitial pneumonia has tradi-
tionally been considered as a separate entity and
not a sequela of cigarette smoking.1–3
Nevertheless, some researchers have suggested
that tobacco smoking may be the common cause of
both emphysema and pulmonary fibrosis. Indirect
support for this hypothesis comes from studies
showing that smoking may be an independent risk
factor in some patients with idiopathic pulmonary
fibrosis and that affected patients often have
evidence of centrilobular emphysema on computed
tomography (CT) scans.4–7
The aim of this work was to describe a cohort
of heavy smokers who presented with con-
comitant upper-lobe bullous emphysema and low-
er-lobe usual interstitial pneumonia with honey-
combing.Subjects and methods
The study group consisted of eight patients,
identified retrospectively, who presented with
dyspnea and cough. All patients were heavy smoker
and referred to our pulmonary clinic because of
suspected emphysema or chronic obstructive lung
disease. Assessment included pulmonary function
tests, chest X-ray and chest CT. Transbronchial
biopsy was performed in three patients. Echocar-
diography for the evaluation of pulmonary hyper-
tension was performed in seven patients. One
patient underwent heart–lung transplantation for
end stage disease.Results
Patient’s characteristics (Table 1)
There were seven male and one female patient
aged 62–76 years. All were heavy smokers (50–100
pack-years). The New York Heart Association
(NYHA) classes ranged between 2 and 4.
Pulmonary function tests (Table 2)
Mean forced vital capacity (FVC) and forced
expiratory volume in 1 s (FEV1) were 86713.3,
78.1720, respectively, and mean FEV1/FVC was
7077.9, indicating mild obstruction combine with
restriction. Mean residual volume (RV) and total
lung capacity (TLC) were 98721, 86710.9, re-
spectively, and mean RV/TLC was 4476.4, indicat-
ing normal to reduced lung volumes with no
significant hyperinflation. The most prominent
feature in all patients was a very low diffusion
capacity (mean 2475.65ml/min/mmHg) and mark-
edly reduced arterial oxygen saturation (mean
8574.8 on room air).
Radiological findings (Table 3)
Chest X-rays
Hyperlucency of the apexes was noted in all
patients, combined with coarse reticular pattern
at the bases and diminished lung volume (Fig. 1A
and B).
Chest CT
The apexes showed bilateral upper-lobe emphyse-
ma in all cases. In four patients, large emphyse-
matous, bulluos changes were noted (Figs. 2A
and 3A). The others showed small emphysematous
cysts.
At the bases there was thickening and distortion
of the interstitum, areas of honeycombing and
traction bronchiectasis. These changes were typi-
cally located at the peripheral lung zones. Four
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Table 2 Pulmonary function tests.
Pt. no. FVC % (l) FEV1 % (l) FEV1/FVC FEF 50% RV % (l) TLC % (l) RV/TLC DLCO % SAT % (RA)
1 106(3.7) 110(3) 81 87(3.4) 121(2.9) 104(6.4) 44 32 87
2 77(2.12) 65(1.42) 67 31(1/01) 105(2.3) 87(4.3) 53 25 90
3 68(2.61) 57(1.69) 65 25(1.04) 122(3.1) 85(5.74) 54 16 80
4 89(2.9) 65(1.69) 58 19(0.87) 82(1.55) 77(4.3) 36 22 88
5 98(2.8) 105(2.1) 80 109(3.6) 72(1.82) 85(4.83) 38 27 76
6 89(3.26) 77(2.16) 66 36(1.42) 92(2.32) 86(5.56) 42 20 88
7 70(2.47) 64(1.74) 70 35(1.34) 74(1.85) 68(4.33) 43 24 85
8 90(3.45) 87(2.59) 75 64(2.7) 118(2.51) 96(6.16) 41 74 88
FVC ¼ forced vital capacity; FEV1 ¼ forced expiratory volume in 1 s; FEF 50 ¼ forced expiratory flow in 50% of the volume;
RV ¼ residual volume; TLC ¼ total lung capacity; DLCO ¼ pulmonary diffusion capacity for carbon monoxide; SAT ¼ oxygen
saturation, room air.
Table 1 Patient’s characteristics.
Pt. no. Sex/age
(years)
Smoking
(pack-years)
Symptoms NYHA PA Comments
1 M/65 60 Dyspnea cough 4 55–80 Heart–lung transplantation
Triple vessel CAD, NSCLC
2 F/71 50 Dyspnea cough 4 44 TBB
3 M/68 60 Dyspnea cough 4 80 Triple vessel CAD, Died
4 M/62 60 Dyspnea cough 2–3 40 NSCLC
5 M/76 60 Dyspnea cough 4 35 CAD
6 M/68 100 Dyspnea cough 3–4 80 CAD
7 M/71 50 Dyspnea 2–3 ND
8 M/72 80 Cough 2–3 30 CAD
NYHA—New York heart association classification.
PA—estimated pulmonary artery (sys pressure mmHg).
CAD—coronary artery disease.
NSCLC—non-small cell lung cancer; ND—not done.
A. Grubstein et al.950patients had in addition ground glass opacities at
the lung bases (Figs. 2B and 3B). In one of them the
opacities and fibrosis had evolved over 6 years from
delicate increased interstitial markings, distributed
subpleurally. This patient underwent heart–lung
transplantation with pathological confirmation of
the radiographic findings of concomitant emphyse-
ma and usual interstitial pneumonia.
Two patients had mediastinal lymphadenopathy
in addition to the parenchymal findings.Pathological findings
In the patient after heart–lung transplantation,
both lungs showed at the bases severe, diffuse
fibrosing interstitial lung disease, most consistent
with usual interstitial pneumonitis (UIP). Alveolarsepta were thickened by collagen fibrosis with
inconspicuous lymphoid infiltrate. Focally bony
metaplasia was seen, as well as alveolar macro-
phages accumulation resembling desquamative
interstitial pneumonia in some areas. Most of the
macrophages were pigmented (smoker’s macro-
phages), and some contained large globules of
hemosiderin. Scattered multinucleated giant cells
were seen as well. Honeycombing was observed in
the periphery of the lower lobes. The upper lobes
on both sides showed severe emphysema with
bullous formation (Fig. 4A and B). In the left lower
lobe of the left lung, squamous cell carcinoma in
the area of fibrosis was found, which was not known
prior to the surgery.
Pathological study of the transbronchial biopsy
specimens, although limited, revealed fibrosis in
all patients, and accumulation of pigmented
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Table 3 Radiological characteristic.
Case Upper lobes Lower lobes Mediastinum
1 Bilateral emphysema
with bulla formation
Septal thickening, architectural distortion
honeycombing, traction bronchiectasis
2 Bilateral emphysema
with bulla formation
Septal thickening, architectural distortion
honeycombing, traction bronchiectasis
3 Bilateral emphysema
with bulla formation
Ground glass opacities, mild septal thickening,
architectural distortion, mainly subpleural
distribution
Mediastinal
lymphadenopathy
4 Bilateral emphysema
with bulla formation
Ground glass opacities, mild septal thickening,
architectural distortion, mainly subpleural
distribution
Mediastinal
lymphadenopathy
5 Bilateral emphysema Septal thickening, architectural distortion
honeycombing, traction bronchiectasis
6 Bilateral emphysema Ground glass, pleural effusion
7 Bilateral emphysema
with bulla formation
Ground glass opacities, mild septal thickening,
architectural distortion, mainly subpleural
distribution
8 Bilateral emphysema Septal thickening, architectural distortion
honeycombing, traction bronchiectasis
Pulmonary interstitial diseases 951macrophages in one. In one patient, cytology exam
of the transbronchial needle aspiration of subcar-
inal lymph node showed non-small cell lung cancer.
Echocardiography
Moderate-to-severe pulmonary hypertension was
found in almost all patients 7/8 (ranged
44–80mmHg) (Table 1). Coronary artery disease a
common finding as well 5/8.Discussion
Smoking-related lung diseases include emphysema,
chronic bronchitis, and respiratory bronchiolitis
alone or in association with interstitial pneumonia,
desquamative interstitial pneumonia and Langer-
hans cell histiocytosis.2,8 Not infrequently, how-
ever, more than one pattern can be seen in a single
patient on biopsy, lung function tests and imaging.
Emphysema is characterized by permanent,
abnormal enlargement of airspaces distal to the
terminal bronchioles, accompanied by destruction
of their walls. The destructive mechanisms that
cause emphysema do not, by definition, include
thickening of the alveolar septa and fibrosis.
Accordingly, pulmonary function tests in emphyse-
ma show obstruction, hyperinflation and decreased
diffusion capacity, whereas in interstitial lung
disease and fibrosis lung volumes are reduced.9In smoking-related respiratory bronchiolitis, the
damage to small airways is manifested by the
accumulation of pigmented macrophages within
the respiratory bronchiole and adjutant’s alveoli.
Desquamative interstitial pneumonia occurs more
peripheraly and is characterized by the accumula-
tion of macrophages within the alveoli. In between
exists respiratory bronchiolitis-associated intersti-
tial lung disease. These pathological entities can be
considered as part of the spectrum of the same
disease process.2,8
In all our patients the pathology, imaging and
lung function tests found coexistent bulluos em-
physema on the upper lobes and interstitial fibrosis
on the lower lobes. In none of the patients did the
biopsy show bronchial or peribronchial interstitial
fibrosis to suggest respiratory bronchiolitis-asso-
ciated interstitial pneumonia (although a small
transbronchial biopsy can miss this diagnosis). In
the first case (post–lung–heart transplantation)
multiple foci of pigmented macrophages were
noticed microscopically. The same picture was
found in another patient on transbronchial biopsy,
again pointing to smoking the probable cause.
In desquamative interstitial pneumonia, there is
relatively little fibrosis compared with usual inter-
stitial pneumonia. Although desquamative inter-
stitial pneumonia with fibrosis is well recognized, it
is not considered to be an earlier (cellular) stage of
cryptogenic fibrosing alveolitis.2,3,8 The most com-
mon radiological findings are bilateral ground-glass
opacities distributed in the middle and lower
ARTICLE IN PRESS
Figure 1 (A,B). Posteroanterior chest radiographs form
(A) a 71-year old female and (B) 60-year old male, both
heavy smokers. Hyperlucency of both upper lung zones
combine with reticular pattern at the bases is seen.
Figure 2 (A,B). CT sections showing marked bullous
formation in the apices (A) and architectural distortion
with honeycombing and ground glass opacities at the
bases (B).
A. Grubstein et al.952zones. In patients with respiratory bronchiolitis-
associated interstitial pneumonia, high-resolution
CT may show centrilobular nodules. Emphysema, if
present, is rarely extensive. Thickening of inter-
lobular septa may also be present, but again, not as
a dominant feature.12,6,8
Ninety percent of all cases of Langerhans cell
histiocytosis are smokers. The disease is character-
ized by nodular lesions that evolve into cysts, with
sparing of the costophrenic recesses and the tip of
the lingula.8 In all our patients, the fibrotic changes
were predominantly basal, mostly peripheral, and
the costophrenic recesses and the tip of the lingula
were involved. Moreover, the bullous changes in the
upper lobe are distinct from the thin-wall cyst
typically seen in Langerhans cell histiocytosis.The radiological appearance of upper-lobe bul-
lous emphysema is well known. The lower lobes are
typically compressed, with apparently increased
interstitial markings. In our patients, however,
there was a genuine interstitial process with a
basal distribution. This finding was confirmed on
the pathology examination. Moreover, in upper-
lobe emphysema, there is a severe obstructive
pattern and hyperinflation on pulmonary function
tests, unlike our patients, who had reduced or
preserved lung volumes, restriction and severe
reduction in diffusion capacity.
Can smoking cause both pathological changes in
the same patient, namely, destruction of the
alveoli wall on the one hand, and fibrosis on the
other? In a histopathologic study of autopsied lungs
from 1824 subjects, Auerbauch et al.10 reported
that smoking could induce, indeed, both these
processes. Wiggins et al.6 in a study of patients with
cryptogenic fibrosing alveolitis and preserved lung
volumes suggested that in many of these cases,
this combination appears to reflect coincidental
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Figure 3 (A,B). CT section showing emphysema at the
apices (A) and traction bronchiectasis, honeycombing as
signs of fibrosis at the bases (B).
Figure 4 (A,B). Post heart–lung transplantation pathol-
ogy. Bases: Severe fibrosing interstitial lung disease.
Alveolar septa thickened by collagen fibrosis. Macro-
phages accumulation (A). Upper lobes: Severe emphyse-
ma with bullous formation (B).
Pulmonary interstitial diseases 953emphysema. Doherty et al.7 adopted the same
concept for their findings of upper-lobe emphysema
on high-resolution CT in eight patients proven lung
fibrosis but with preserved lung volumes. These
reports agree with ours, of severe interstitial
fibrosis and normal lung volumes caused by upper-
lobe bulluos emphysema.6,7 A similar report by
Hanninghake et al.12 showed a high-resolution CT
picture of basal fibrosis and apical emphysema in a
patient with usual interstitial pneumonia.
Another puzzling feature is the moderate-to-
severe pulmonary hypertension in most of our
patients. Both chronic obstructive pulmonary dis-
ease as well as interstitial fibrosis may cause
secondary pulmonary hypertension.11 However, in
the setting of combined emphysema/fibrosis, the
presence of pulmonary hypertension could suggest
severe, smoking-related damage to the pulmonary
capillaries. Pulmonary hypertension tends to be of
moderate severity and progress slowly, and is
associated with shorter survival and worse clinical
evolution.13 The vasculopathy is involving both
pulmonary arteries, as well as the coronaryarteries, as is seen by the high incidence of severe
coronary artery disease in our patients.
In summary, the apparent contradictory coex-
istence of emphysema and pulmonary fibrosis is
reported here in eight heavy smokers and is in
accordance with several emerging reports.
Although smoking seems to be able to induce both
pathologies, the question of whether, in these
cases, it is directly responsible for the interstitial
lung disease or whether the combined disorder is
coincidental findings, is still unresolved. We believe
that in some patients, smoking is destructive at
several levels, and leads to simultaneous emphy-
sema and lung fibrosis, as well as pulmonary
hypertension and coronary artery disease. As the
association between smoking and fibrosis continue
to unfold, we suggest that the spectrum of
respiratory bronchiolitis, respiratory bronchiolitis-
associated interstitial pneumonia and desquama-
tive interstitial pneumonia should be expanded to
include pulmonary fibrosis (usual interstitial pneu-
monitis). Further studies are needed to explore the
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A. Grubstein et al.954possible genetic and pathophysiology mechanisms
of this unusual syndrome.References
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